Nova Scotia Expands COVID-19 Vaccine Options with AstraZeneca Approval

Strategic Insights -

Nova Scotia's Chief Medical Officer, Dr. Robert Strang, has stated that the province will offer the AstraZeneca vaccine as an option for COVID-19 vaccination, in addition to the Moderna and Pfizer vaccines. The AstraZeneca vaccine, a viral vector vaccine, has been approved by Health Canada and has shown to be 62% effective against COVID-19 in clinical trials. With 13,000 doses of the AstraZeneca vaccine set to arrive in the province, the government is preparing information for Nova Scotians to make an informed decision about which vaccine to choose. The province will have to pivot its distribution plan to accommodate the AstraZeneca vaccine, which is only recommended for individuals under the age of 65.

Key Takeaways:

  • The AstraZeneca vaccine has been approved by Health Canada and is expected to arrive in Nova Scotia shortly.
  • The vaccine is 62% effective against COVID-19, compared to the Moderna and Pfizer vaccines which are over 90% effective.
  • The province will need to pivot its distribution plan to accommodate the AstraZeneca vaccine, which is only recommended for individuals under the age of 65.
  • The vaccine is easier to store and transport than the other COVID-19 vaccines, requiring only temperatures between 2 and 8 degrees Celsius.
  • The province has partnered with Doctors Nova Scotia and the pharmacy association to administer the first batch of AstraZeneca vaccines to Nova Scotians between the ages of 50 and 64.
  • Appointments will be available on a first-come-first-serve basis through an online booking portal, with 26 locations across the province offering about 300 doses each.

Statistics:

  • 13,000 doses of the AstraZeneca vaccine will arrive in Nova Scotia shortly.
  • The vaccine is expected to decrease the province's COVID-19 transmission rate by up to 62% among those under the age of 65.
  • 26 locations across the province will offer the AstraZeneca vaccine, with each location providing about 300 doses.
  • The online booking portal for the vaccine is expected to be available shortly, offering appointments on a first-come-first-serve basis.

Sources:

  • Health Canada (no date)
  • "Nova Scotia expands COVID-19 vaccine options with AstraZeneca approval," CBBC News (no date)
  • Reuters (no date)
  • "AstraZeneca vaccine approved by Health Canada," CBC News (February 26, 2021)
  • "Nova Scotia to offer AstraZeneca vaccine to those between 50 and 64," Nova Scotia News (no date)